Dover has entered into a definitive agreement to acquire Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and control instruments for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s merchandise will increase Dover’s biopharma single-use manufacturing offering, which already consists of Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Inexpensive , Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in income through the full year 2022.
When the deal closes, Malema will become a half of the PSG business unit within Dover’s Pumps & Process Solutions phase.
“ Endorsed see an amazing long-term growth alternative within the bioprocessing trade driven by a powerful and rising pipeline of efficient novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more environment friendly single-use manufacturing processes supports a robust outlook for our offerings of single-use parts to end-customers. We imagine that pairing Malema’s expertise with our existing portfolio of single-use pumps for biopharma processing will tremendously enhance the accuracy and worth proposition of our solutions to our prospects.”
“We are methodically building out our biopharma platform via proactive capacity additions, new product growth, and opportunistic acquisitions of highly-attractive niche element technologies,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and additional strengthens our sensor portfolio with new proprietary know-how. In addition to engaging biopharma applications, we count on sturdy growth within the semiconductor area on the capacity expansion and re-shoring tailwinds.”
Share